Exploratory Phase II Clinical Trial to Evaluate the Efficacy and Safety of Clotinab (Abciximab) in Acute Myocardial Infarction Patients: Multicenter, Randomized, Double Blind, Placebo-controlled and Parallel Group Trial

Trial Profile

Exploratory Phase II Clinical Trial to Evaluate the Efficacy and Safety of Clotinab (Abciximab) in Acute Myocardial Infarction Patients: Multicenter, Randomized, Double Blind, Placebo-controlled and Parallel Group Trial

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Apr 2017

At a glance

  • Drugs Abciximab (Primary)
  • Indications Myocardial infarction
  • Focus Therapeutic Use
  • Sponsors ISU Abxis
  • Most Recent Events

    • 05 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top